Buying Buzz: HCA Healthcare Inc. [HCA] 10% Owner Elcan Patricia F purchases 325 shares of the company

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. HCA Healthcare Inc. shares valued at $64,564 were purchased by Elcan Patricia F on Jul 25. At $198.66 per share, Elcan Patricia F acquired 325 shares. The insider’s holdings grew to 89,337 shares worth approximately $19.0 million following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Berres Jennifer sold 2,358 shares, netting a total of over 516,086 in proceeds. Following the sale of shares at $218.87 each, the insider now holds 11,392 shares.

Before that, Whalen Kathleen M had sold 500 shares from its account. In a trade valued at $107,690, the SVP & Chief Ethics Officer traded HCA Healthcare Inc. shares for $215.38 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $2.42 million.

As published in a research note from BMO Capital Markets on July 06, 2022, HCA Healthcare Inc. [HCA] has been rated down from a Market perform to an Underperform and the price target has been revised to $160 from $233. This represents a -32.95% premium over Thursday’s closing price. Analysts at Loop Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 27, 2022, Bernstein has increased its “Mkt perform” rating to a “an Outperform” for HCA. Earlier on March 29, 2022, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for HCA stock.

Analyzing HCA’s Price Performance

On Thursday, HCA Healthcare Inc. [NYSE: HCA] plunged -1.73% to $212.72. The stock’s lowest price that day was $212.31, but it reached a high of $217.04 in the same session. During the last five days, there has been a surge of approximately 1.40%. Over the course of the year, HCA Healthcare Inc. shares have dropped approximately -17.20%. Shares of the company reached a 52-week high of $279.02 on 04/21/22 and a 52-week low of $164.47 on 07/14/22. A 50-day SMA is recorded $189.87, while a 200-day SMA reached $230.71. Nevertheless, trading volume fell to 1.09 million shares from 1.35 million shares the previous day.

Support And Resistance Levels for HCA Healthcare Inc. (HCA)

According to the 24-hour chart, there is a support level at 211.01, which, if violated, would cause prices to drop to 209.29. In the upper region, resistance lies at 215.74. The next price resistance is at 218.75. RSI (Relative Strength Index) is 67.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 14.05, which suggests the price will increase in the coming days. Percent R is at 10.94%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is HCA Healthcare Inc. subject to short interest?

Stocks of HCA Healthcare Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.49 million shares to 4.57 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 5.06 million shares. A decline of -10.72% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.03 of the overall float, the days-to-cover ratio (short ratio) decline to 2.03.

Which companies own the most shares of HCA Healthcare Inc. (HCA)?

According to The Vanguard Group, Inc. filings, the company currently owns 18,118,813 shares, which is about 6.13% of the total HCA shares outstanding. The investor’s shares have appreciated by 202,305 from its previous 13-F filing of 17916508.0 shares. With the completion of the sale transaction, T. Rowe Price Associates, Inc.’s stake is now worth $2,533,485,173. Wellington Management Co. LLP acquire a 4.09% interest valued at $2.41 billion while BlackRock Fund Advisors purchased a 62,088 stake. A total of -197,013 shares of HCA Healthcare Inc. were bought by SSgA Funds Management, Inc. during the quarter, and 298,323 were bought by Sanders Capital LLC. In its current portfolio, Harris Associates LP holds 7,646,769 shares valued at $1.29 billion.

In terms of HCA Healthcare Inc. share price expectations, FactSet research, analysts set an average price target of $232.00 in the next 12 months, up nearly 10.41% from the previous closing price of $216.47. Analysts anticipate HCA Healthcare Inc. stock to reach $283.00 by 2022, with the lowest price target being $150.00. In spite of this, 27 analysts ranked HCA Healthcare Inc. stock as an Overweight at the end of 2022. On January 10, 2022, Citigroup assigned a price target of “a Buy” to the stock and resumed coverage with a $306.

LEAVE A REPLY

Please enter your comment!
Please enter your name here